US 11,918,707 B2
Implant, preferably for the treatment of an acetabular defect
Silke Koenig, Rottweil (DE)
Assigned to AESCULAP AG, Tuttlingen (DE)
Filed by Aesculap AG, Tuttlingen (DE)
Filed on Jul. 7, 2021, as Appl. No. 17/369,319.
Application 17/369,319 is a continuation of application No. 16/323,078, granted, now 11,110,208, previously published as PCT/EP2017/069376, filed on Aug. 1, 2017.
Claims priority of application No. 10 2016 214 258.5 (DE), filed on Aug. 2, 2016.
Prior Publication US 2021/0338903 A1, Nov. 4, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 27/58 (2006.01); A61F 2/30 (2006.01); A61L 27/04 (2006.01); A61L 27/18 (2006.01); A61L 27/24 (2006.01); A61L 27/36 (2006.01); A61L 27/54 (2006.01); A61L 27/56 (2006.01)
CPC A61L 27/58 (2013.01) [A61L 27/047 (2013.01); A61L 27/18 (2013.01); A61L 27/24 (2013.01); A61L 27/3604 (2013.01); A61L 27/3625 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61L 2300/406 (2013.01); A61L 2430/02 (2013.01); A61L 2430/24 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An implant for use in treating an acetabular defect, having at least two flat structures which are arranged directly on top of each other and attached to one another along the edge areas of each flat structure, wherein the at least two flat structures contain a material that is at least partially decomposable or resorbable in vivo, wherein the at least two flat structures comprise a central area and only three elongated functional areas, wherein the functional areas extend out from the central area of the at least two flat structures, wherein a cavity is formed in between the at least two flat structures, wherein the material has a randomized fiber structure.